[HTML][HTML] Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome

M Beraud, S Al Hashami, M Lozano, A Bah… - … and Apheresis Science, 2022 - Elsevier
The risk of mortality in patients with coronavirus disease 2019 (COVID-19) is largely related
to an excessive immune response, resulting in a hyperinflammatory and hypercoagulable …

[HTML][HTML] Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome

M Beraud, S Al Hashami, M Lozano… - Transfusion and …, 2022 - ncbi.nlm.nih.gov
The risk of mortality in patients with coronavirus disease 2019 (COVID-19) is largely related
to an excessive immune response, resulting in a hyperinflammatory and hypercoagulable …

[HTML][HTML] Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome

M Beraud, S Al Hashami, M Lozano, A Bah… - … and Apheresis Science, 2022 - trasci.com
The risk of mortality in patients with coronavirus disease 2019 (COVID-19) is largely related
to an excessive immune response, resulting in a hyperinflammatory and hypercoagulable …

Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome

M Beraud, S Al Hashami, M Lozano… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The risk of mortality in patients with coronavirus disease 2019 (COVID-19) is largely related
to an excessive immune response, resulting in a hyperinflammatory and hypercoagulable …

Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome.

M Beraud, SA Hashami, M Lozano, A Bah… - … and Apheresis Science …, 2022 - europepmc.org
The risk of mortality in patients with coronavirus disease 2019 (COVID-19) is largely related
to an excessive immune response, resulting in a hyperinflammatory and hypercoagulable …

Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome.

M Beraud, SA Hashami, M Lozano, A Bah… - … and Apheresis Science …, 2022 - europepmc.org
The risk of mortality in patients with coronavirus disease 2019 (COVID-19) is largely related
to an excessive immune response, resulting in a hyperinflammatory and hypercoagulable …